BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21962134)

  • 1. Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.
    Kvaskoff M; Whiteman DC; Zhao ZZ; Montgomery GW; Martin NG; Hayward NK; Duffy DL
    Twin Res Hum Genet; 2011 Oct; 14(5):422-32. PubMed ID: 21962134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.
    Thomas NE; Edmiston SN; Orlow I; Kanetsky PA; Luo L; Gibbs DC; Parrish EA; Hao H; Busam KJ; Armstrong BK; Kricker A; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Ollila DW; Begg CB; Berwick M; Conway K;
    J Invest Dermatol; 2018 Nov; 138(11):2398-2404. PubMed ID: 29753029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.
    Duffy DL; Zhu G; Li X; Sanna M; Iles MM; Jacobs LC; Evans DM; Yazar S; Beesley J; Law MH; Kraft P; Visconti A; Taylor JC; Liu F; Wright MJ; Henders AK; Bowdler L; Glass D; Ikram MA; Uitterlinden AG; Madden PA; Heath AC; Nelson EC; Green AC; Chanock S; Barrett JH; Brown MA; Hayward NK; MacGregor S; Sturm RA; Hewitt AW; ; Kayser M; Hunter DJ; Newton Bishop JA; Spector TD; Montgomery GW; Mackey DA; Smith GD; Nijsten TE; Bishop DT; Bataille V; Falchi M; Han J; Martin NG
    Nat Commun; 2018 Nov; 9(1):4774. PubMed ID: 30429480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC).
    Orlow I; Satagopan JM; Berwick M; Enriquez HL; White KA; Cheung K; Dusza SW; Oliveria SA; Marchetti MA; Scope A; Marghoob AA; Halpern AC
    Br J Dermatol; 2015 Apr; 172(4):1081-9. PubMed ID: 25307738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of germline genetic variants on dermoscopic features of melanoma.
    Pozzobon FC; Tell-Marti G; Calbet-Llopart N; Barreiro A; Espinosa N; Potrony M; Alejo B; Podlipnik S; Combalia M; Puig-Butillé JA; Carrera C; Malvehy J; Puig S
    Pigment Cell Melanoma Res; 2021 May; 34(3):618-628. PubMed ID: 33342058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.
    Gibbs DC; Orlow I; Bramson JI; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
    J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26857527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations.
    Yang XR; Liang X; Pfeiffer RM; Wheeler W; Maeder D; Burdette L; Yeager M; Chanock S; Tucker MA; Goldstein AM
    Fam Cancer; 2010 Dec; 9(4):625-33. PubMed ID: 20574843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRF4 variants have age-specific effects on nevus count and predispose to melanoma.
    Duffy DL; Iles MM; Glass D; Zhu G; Barrett JH; Höiom V; Zhao ZZ; Sturm RA; Soranzo N; Hammond C; Kvaskoff M; Whiteman DC; Mangino M; Hansson J; Newton-Bishop JA; ; Bataille V; Hayward NK; Martin NG; Bishop DT; Spector TD; Montgomery GW
    Am J Hum Genet; 2010 Jul; 87(1):6-16. PubMed ID: 20602913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study.
    Laino AM; Berry EG; Jagirdar K; Lee KJ; Duffy DL; Soyer HP; Sturm RA
    Br J Dermatol; 2018 May; 178(5):1119-1127. PubMed ID: 29315480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma susceptibility variant rs869330 in the MTAP gene is associated with melanoma outcome.
    Marasigan V; Güvenç C; van den Oord JJ; Stas M; Boecxstaens V; Bechter O; Wolter P; Lambrechts D; Garmyn M
    Melanoma Res; 2019 Dec; 29(6):590-595. PubMed ID: 30681428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.
    Behrmann I; Wallner S; Komyod W; Heinrich PC; Schuierer M; Buettner R; Bosserhoff AK
    Am J Pathol; 2003 Aug; 163(2):683-90. PubMed ID: 12875987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.
    Whiteman DC; Watt P; Purdie DM; Hughes MC; Hayward NK; Green AC
    J Natl Cancer Inst; 2003 Jun; 95(11):806-12. PubMed ID: 12783935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin Pigmentation Genetics for the Clinic.
    Ainger SA; Jagirdar K; Lee KJ; Soyer HP; Sturm RA
    Dermatology; 2017; 233(1):1-15. PubMed ID: 28463841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas.
    Bastian BC; Xiong J; Frieden IJ; Williams ML; Chou P; Busam K; Pinkel D; LeBoit PE
    Am J Pathol; 2002 Oct; 161(4):1163-9. PubMed ID: 12368190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma.
    Purdue MP; From L; Armstrong BK; Kricker A; Gallagher RP; McLaughlin JR; Klar NS; Marrett LD;
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2015-22. PubMed ID: 16103454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi.
    Falchi M; Bataille V; Hayward NK; Duffy DL; Bishop JA; Pastinen T; Cervino A; Zhao ZZ; Deloukas P; Soranzo N; Elder DE; Barrett JH; Martin NG; Bishop DT; Montgomery GW; Spector TD
    Nat Genet; 2009 Aug; 41(8):915-9. PubMed ID: 19578365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
    McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
    Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific determinants of cutaneous melanoma: a case-case comparison of patients with tumors arising on the head or trunk.
    Kvaskoff M; Pandeya N; Green AC; Perry S; Baxter C; Davis MB; Mortimore R; Westacott L; Wood D; Triscott J; Williamson R; Whiteman DC
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2222-31. PubMed ID: 24083994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
    Gathany AH; Hartge P; Davis S; Cerhan JR; Severson RK; Cozen W; Rothman N; Chanock SJ; Wang SS
    Cancer Causes Control; 2009 Oct; 20(8):1291-302. PubMed ID: 19396635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.